238 related articles for article (PubMed ID: 14563938)
1. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?
Lange CA
Mol Endocrinol; 2004 Feb; 18(2):269-78. PubMed ID: 14563938
[TBL] [Abstract][Full Text] [Related]
2. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer.
Lange CA; Gioeli D; Hammes SR; Marker PC
Annu Rev Physiol; 2007; 69():171-99. PubMed ID: 17037979
[TBL] [Abstract][Full Text] [Related]
3. Integration of progesterone receptor action with rapid signaling events in breast cancer models.
Lange CA
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):203-12. PubMed ID: 17964138
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
[TBL] [Abstract][Full Text] [Related]
5. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
6. Receptor mechanisms mediating non-genomic actions of sex steroids.
Boonyaratanakornkit V; Edwards DP
Semin Reprod Med; 2007 May; 25(3):139-53. PubMed ID: 17447204
[TBL] [Abstract][Full Text] [Related]
7. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation.
Manna PR; Chandrala SP; Jo Y; Stocco DM
J Mol Endocrinol; 2006 Aug; 37(1):81-95. PubMed ID: 16901926
[TBL] [Abstract][Full Text] [Related]
8. Signaling mechanisms in progesterone-neurotransmitter interactions.
Mani SK
Neuroscience; 2006; 138(3):773-81. PubMed ID: 16310962
[TBL] [Abstract][Full Text] [Related]
9. Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines.
Migliaccio A; Castoria G; Giovannelli P; Auricchio F
Mol Cell Endocrinol; 2010 Oct; 327(1-2):19-24. PubMed ID: 20603181
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormone action in the brain: cross-talk between signalling pathways.
Mani SK; Portillo W; Reyna A
J Neuroendocrinol; 2009 Mar; 21(4):243-7. PubMed ID: 19187467
[TBL] [Abstract][Full Text] [Related]
11. MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association.
Qiu M; Lange CA
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):147-57. PubMed ID: 12943699
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
Shen T; Horwitz KB; Lange CA
Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
[TBL] [Abstract][Full Text] [Related]
13. In a nongenomic action, steroid hormone 20-hydroxyecdysone induces phosphorylation of cyclin-dependent kinase 10 to promote gene transcription.
Liu W; Cai MJ; Wang JX; Zhao XF
Endocrinology; 2014 May; 155(5):1738-50. PubMed ID: 24517229
[TBL] [Abstract][Full Text] [Related]
14. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
15. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones.
Boonyaratanakornkit V; Edwards DP
Essays Biochem; 2004; 40():105-20. PubMed ID: 15242342
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between growth factor and progesterone receptor signaling pathways: implications for breast cancer cell growth.
Pierson-Mullany LK; Skildum A; Faivre E; Lange CA
Breast Dis; 2003; 18():21-31. PubMed ID: 15687686
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation.
Shupnik MA
Oncogene; 2004 Oct; 23(48):7979-89. PubMed ID: 15489915
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
Skildum A; Faivre E; Lange CA
Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
[TBL] [Abstract][Full Text] [Related]
20. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
